Huiling Pei
Impact in
-
- Diabetes Management and Research
- Diabetes Treatment and Management
- Hematology top 5%
- Multiple Myeloma Research and Treatments
Papers in
- Hematology 31
- Multiple Myeloma Research and Treatments 30
- Chronic Myeloid Leukemia Treatments 4
- Oncology 15
- Peptidase Inhibition and Analysis 8
- Cancer Treatment and Pharmacology 6
- Co-authors
- Michel Marre (1 shared paper)David Russell‐Jones (1 shared paper)Simon Heller (1 shared paper)Areti Philotheou (1 shared paper)Ludwig Merker (1 shared paper)Miles Fisher (1 shared paper)Ann Marie Ocampo Francisco (1 shared paper)Éric Renard (1 shared paper)
- Journals
- Blood (11 papers)Journal of Clinical Oncology (6 papers)HemaSphere (3 papers)Blood Advances (2 papers)British Journal of Haematology (1 paper)
- Partner nations
- United StatesFranceNetherlands
In The Last Decade
Huiling Pei
39 papers receiving 596 citations
Peers
Comparison fields: 5 of 66
- Endocrinology, Diabetes and Metabolism 309
- Hematology 195
- Oncology 147
- Surgery 202
- Genetics 110
Countries citing papers authored by Huiling Pei
This map shows the geographic impact of Huiling Pei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huiling Pei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huiling Pei more than expected).
Fields of papers citing papers by Huiling Pei
This network shows the impact of papers produced by Huiling Pei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huiling Pei. The network helps show where Huiling Pei may publish in the future.
Co-authors
The 25 scholars most cited alongside Huiling Pei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 309 | |
| 2 | 2019 | 35 | |
| 3 | 2018 | 32 | |
| 4 | 2019 | 28 | |
| 5 | 2019 | 26 | |
| 6 | 2018 | 21 | |
| 7 | 2020 | 20 | |
| 8 | 2021 | 18 | |
| 9 | 2021 | 13 | |
| 10 | 2022 | 12 | |
| 11 | 2022 | 10 | |
| 12 | 2023 | 10 | |
| 13 | 2018 | 9 | |
| 14 | 2021 | 6 | |
| 15 | 2020 | 6 | |
| 16 | 2018 | 5 | |
| 17 | 2020 | 5 | |
| 18 | 2020 | 5 | |
| 19 | 2023 | 5 | |
| 20 | 2022 | 5 |
About Huiling Pei
Huiling Pei is a scholar working on Hematology, Oncology, Molecular Biology, Genetics and Organic Chemistry, having authored 42 papers that have together received 620 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (30 papers), Chronic Lymphocytic Leukemia Research (8 papers), Peptidase Inhibition and Analysis (8 papers), Synthesis and Biological Evaluation (7 papers), Cancer Treatment and Pharmacology (6 papers), Protein Degradation and Inhibitors (6 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (5 papers) and Chronic Myeloid Leukemia Treatments (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (309 citations), Hematology (195 citations), Oncology (147 citations), Surgery (202 citations) and Genetics (110 citations). Huiling Pei has collaborated with scholars based in United States, France and Netherlands. Frequent co-authors include Michel Marre, David Russell‐Jones, Simon Heller, Areti Philotheou, Ludwig Merker, Miles Fisher, Ann Marie Ocampo Francisco, Éric Renard, Satish K. Garg and John B. Buse. Their work appears in journals such as Blood, Journal of Clinical Oncology, HemaSphere, Blood Advances and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.